Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TH9619 in advanced solid tumors
NCT07151040Phase 2Recruiting
- Sponsor
- One-carbon Therapeutics AB
- Start
- Aug 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of TH9619 in colorectal cancer (CRC), head and neck squamous cell carcinoma (HNSCC), non-small cell lung cancer (NSCLC), gastric cancer (GC), gastroesophageal junction cancer, sponsored by One-carbon Therapeutics AB. Started Aug 2025; status: recruiting.
02
Drugs
TH9619
03
Conditions
colorectal cancer (CRC)head and neck squamous cell carcinoma (HNSCC)non-small cell lung cancer (NSCLC)gastric cancer (GC)gastroesophageal junction cancer
Beyond the preview
Go deeper on NCT07151040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07151040.